From: Death after awakening from post-anoxic coma: the “Best CPC” project
All (n = 196) | OHCA (n = 82) | IHCA (n = 114) | |
---|---|---|---|
Male, n (%) | 132 (67) | 60 (72) | 72 (63) |
Age, years | 73 [62–79] | 73 [65–79] | 73 [60–79] |
Estimated weight, kg | 75 [70–85] | 75 [70–82] | 76 [70–89] |
Comorbidities | |||
Chronic hypertension | 75 (38) | 29 (35) | 46 (40) |
Diabetes | 60 (31) | 24 (29) | 36 (32) |
NYHA III–IV heart failure | 27 (14) | 6 (7) | 21 (18) * |
Chronic coronary artery disease | 86 (44) | 32 (39) | 54 (47) |
Previous vascular neurological disease | 32 (16) | 18 (22) | 14 (12) |
Liver cirrhosis | 17 (9) | 4 (5) | 13 (11) |
COPD/asthma | 50 (26) | 14 (17) | 36 (32) * |
Chronic hemodialysis | 30 (15) | 7 (9) | 23 (20) * |
Immunosuppression | 10 (5) | 4 (5) | 6 (5) |
CA characteristics | |||
Time of ROSC, min | 12 [6–20] | 17 [12–25] | 10 [5–15] * |
Adrenaline, mg | 2 [1–3] | 3 [1–4] | 1 [1–1] * |
Witnessed, n (%) | 167 (85) | 66 (80) | 101 (89) |
Bystander CPR, n (%) | 147 (75) | 52 (63) | 95 (83) * |
Cardiac cause, n (%) | 152 (78) | 60 (73) | 92 (81) |
Non-shockable rhythm, n (%) | 127 (65) | 43 (52) | 84 (74) * |
ECPR, n (%) | 15 (8) | 5 (6) | 10 (9) |
After hospital admission | |||
Lactate on admission, mmol/dL | 5.4 [2.9–8.4] | 5.7 [2.9–8.4] | 5.2 [2.9–8.4] |
Vasopressor use, n (%) | 178 (91) | 74 (90) | 104 (91) |
Dobutamine use, n (%) | 107 (55) | 44 (54) | 63 (55) |
TTM, n (%) | 117 (60) | 66 (80) | 51 (45) * |
Infection, n (%) | 89 (45) | 36 (44) | 53 (46) |
Shock, n (%) | 148 (76) | 69 (84) | 79 (69) * |
IABP, n (%) | 16 (8) | 6 (7) | 10 (9) |
Post-ROSC ECMO, n (%) | 13 (7) | 3 (4) | 10 (9) |
RRT, n (%) | 71 (36) | 17 (21) | 54 (47) * |
MV, n (%) | 195 (99) | 82 (100) | 113 (99) |
Bleeding, n (%)$ | 48 (24) | 16 (20) | 32 (28) |
ICU length of stay, days | 8 [3–16] | 9 [1–16] | 7 [3–15] |